Qianben Wang, Ph.D.
Professor of Pathology
Dr. Qianben Wang earned his Ph.D. in 2002 from the University of Maryland School of Medicine under the supervision of Dr. Joseph Fondell. He conducted his postdoctoral training in Dr. Myles Brown’s lab at Dana-Farber Cancer Institute, Harvard Medical School. He started his faculty career as a tenure-track Assistant Professor in the Department of Molecular and Cellular Biochemistry at The Ohio State University in 2008, and was promoted to the rank of Associate Professor with tenure in 2013. Dr. Wang joined the Department of Pathology at Duke University School of Medicine as a Professor with tenure in December, 2017.
Zhong Chen, Ph.D.
Assistant Professor of Pathology
Dr. Zhong Chen was appointed Assistant Professor in Pathology on December 1, 2017. Dr. Chen received his B.Med from Tianjin Medical University in 2003 and his Ph.D. in 2008 from the Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. He subsequently moved to the Ohio State University, where he held positions as Postdoctoral Fellow (2008–2012), Research Scientist (2012–2016), and Senior Research Scientist (2016–2017). Dr. Chen studies transcriptional regulation using both in vitro and in vivo systems to identify potential molecular therapeutic targets required for the growth and progression of hormone-dependent cancers.
Hongyan Wang, Ph.D.
Senior Research Scientist/Lab Manager
Hongyan received her B.Med. from Capital University of Medical Sciences and M.S. from China Academy of Traditional Chinese Medicine, Beijing, China. She obtained her Ph.D. in Pharmaceutical Sciences from University of Maryland at Baltimore and did her postdoc training at Brigham and Women’s Hospital & Harvard Medical School. She has been working as research scientist at Ohio State University Comprehensive Cancer Center since 2008 before joining Wang’s group at Duke in 2017 as a senior research scientist and lab manager.
Furong Huang, Ph.D.
Furong received his B. Med. from Tianjian Medical University and his Ph.D. degree from National Cancer Center/Cancer Hospital, China Academy of Medical Sciences and Peking Union Medical College in 2020. His current research focuses on studying the epigenetic mechanisms underlying the hormone-dependent cancers.
Zhifen Cui, Ph.D.
Kexin Li, Ph.D.
Kexin received her B. S. from Guangxi Normal University and her M.S. and Ph.D. degrees from China Academy of Medical Sciences and Peking Union Medical College. Her current research focuses on studying the epigenetic mechanisms underlying the neuroendocrine prostate cancer.